Doctors are grappling with a raft of unsparing hospital-acquired superbugs broadly known as anti-microbial resistance or AMR. Are bacterial infections the next big lethal adversary for mankind?
Related Posts
Can Cipla make inhaled insulin a successful option for diabetes patients?
Umang Vohra, Global CEO, Cipla. Will Cipla’s big bet work?; image credit: Company. Synopsis Millions of diabetes patients have to take a painful insulin injection to keep sugar levels in control. Cipla is introducing Afrezza, an inhaled insulin, in India. Will doctors and patients buy this option? A blue travel case of insulin injections is […]
India Diabetes: Curbing the surge of diabetes in India needs collaborative effort: Novo Nordisk CEO
Lars Fruergaard Jorgensen, global CEO, Novo Nordisk; image credit: Company Synopsis Lars Fruergaard Jørgensen, the CEO of Novo Nordisk, the world’s largest producer of insulins, shares his thoughts on how to arrest the growing numbers of diabetes patients; the company’s blockbuster weight-loss drug Wegovy; regulating medicine prices; and more. For Lars Fruergaard Jørgensen, CEO, Novo […]
Carrying organs to blood samples, drones can change healthcare. But not before limitations are fixed.
Technicians fly a drone to deliver medical supplies during testing at Gauribidanur, near Banglore. Synopsis The use of drones in healthcare is in its test phase. There are already instances of medical drones transporting live organs for transplant, delivering vaccines in remote areas, or carrying oxygen cylinders. However, for medical drones to become mainstream, technical, […]
